Form 4: AdaptHealth Director Terence Connors Increases Stake Through Share Grant

AdaptHealth Corp. Director Terence J. Connors acquired 21,346 shares of common stock, increasing his direct beneficial ownership to 76,263 shares.

Summary

• Terence J. Connors, a Director of AdaptHealth Corp. (AHCO), acquired 21,346 shares of common stock.
• The transaction occurred on June 26, 2025.
• The acquisition price was $0 per share, indicating a grant or award rather than a market purchase.
• Following this transaction, Mr. Connors directly beneficially owns a total of 76,263 shares of AdaptHealth Corp. common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if granted, is generally a positive signal of insider confidence in the company's future, aligning their interests with shareholders. The $0 price indicates a grant, which is less impactful than a direct market purchase but still an increase in ownership.

Positives

• A director increasing their stake, even through a grant, can signal confidence in the company's future prospects.
• The increase in direct beneficial ownership by a director aligns their interests more closely with those of shareholders.

Negatives

• The acquisition price of $0 suggests the shares were granted, potentially as part of compensation, rather than purchased on the open market, which might be viewed differently by some investors than a cash purchase.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Management Comments

• This Power of Attorney authorizes, but does not require, each Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information.
• Any documents prepared or executed by either Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as such Attorney-in-Fact, in his or her discretion, deems necessary or desirable.
• Neither the Company nor the Attorneys-in-Fact assume any liability for the undersigned's responsibility to comply with the requirements of Section 13 or Section 16 of the Exchange Act or Rule 144, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act.
• This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 13 or Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 13 or Section 16 of the Exchange Act.

Industry Context

This Form 4 filing is a routine insider transaction report and does not provide specific industry context or trends for the healthcare equipment and services sector. It reflects an individual director's shareholdings rather than broader industry dynamics.

Corporate Governance

Stakeholder Impact

• Shareholders: The increase in director ownership may be viewed positively as it aligns management interests with shareholder value.
• Management/Employees: The grant of shares to a director is often part of compensation, which can incentivize performance.

Key Dates

Recommendation

Keywords

AdaptHealth Corp, AHCO, Terence J Connors, Director, SEC Form 4, Insider Trading, Share Acquisition, Beneficial Ownership, Common Stock, Corporate Governance